Pay in 4 interest-free payments of $6.68 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Gina: Before we get into it with Aayushi, lets clarify something
body weight reduction FDA-reviewed clinical trial data 72wk Sustained, continued results FDA-approved trial program 2 Hormone pathways targeted GLP-1 + GIP dual activation 400k+ Patients helped nationwide 20,000+ five-star reviews The science The Only Medication That Targets Both Hunger Hormones Tirzepatide activates both the GLP-1 and GIP receptors at once, working on two of the systems that influence hunger and fat metabolism instead of just one
Intravenous administration has been shown to have a short window of efficacy
Additionally, it's important to consider how it helps treat diabetes and obesity
Biol Rev Camb Philos Soc (2011) 86(2):493510
This outcome positions retatrutide as a highly effective candidate, potentially more so than current treatments like semaglutide (Wegovy) and tirzepatide (Zepbound)
US$ 26.30
US$ 21.11
US$ 23.42
US$ 28.58
US$ 22.27
